Today is the day! Join us at 4:30 pm ET for a discussion on the current treatment landscape for idiopathic pulmonary fibrosis, the significant unmet needs that remain, and emerging therapies, including our lead asset, LTI-03. Read the release here: https://bit.ly/3UIkjF7 ? #IPF?
Also did a Teams Interview with Jennifer? Rodriguez for Data entry position they emailed me a Check for 1500 dollars for equipment. It is fake
Join Clario on May 16 for an enlightening webinar that explores Parkinson’s disease endpoint data collection. Our experts will delve into topics that include: -Sensitivity of digital measures in disease progression monitoring -Efficacy and quality of life evaluations using clinical scales and patient-reported outcomes -Imaging features for biomarker-guided drug development Register now to gain invaluable insights in Parkinson's disease research: https://lnkd.in/eCN3y5jb #ParkinsonsResearch #EndpointDataCollection #Webinar
Progression-free survival and overall survival benefits of adding chemotherapy to gefitinib were sustained at 5 years, confirming earlier results reported at median follow-up of 17 months. https://ja.ma/3zJ4AwY
Our first blog is now live! In this blog, we will unravel the intricate web of Procalcitonin's significance in identifying sepsis early on and optimizing antibiotic treatment. Let us explore how this biomarker is poised to transform patient care, streamline clinical decision-making and contribute to a paradigm shift in the fight against sepsis. Stay tuned for insights, innovations, and the latest advancements in diagnostic technology that will shape the future of healthcare. Read the full blog here: https://lnkd.in/dhRC3fXn . . #diasysindia #blog #blogpost #procalcitonin #sepsis #antibiotic #insights
AGM - Strategic and Operational Marketing | Business Development at DiaSys Diagnostics India Pvt Ltd
The prevalence of sepsis need to be controlled by timely diagnosis and monitoring of Procalcitonin. The below blog gives you an overview of why diagnosis of Sepsis is important. #procalcitonin #sepsisawareness #sepsis DiaSys Diagnostics India Pvt Ltd DiaSys Diagnostic Systems GmbH
Our first blog is now live! In this blog, we will unravel the intricate web of Procalcitonin's significance in identifying sepsis early on and optimizing antibiotic treatment. Let us explore how this biomarker is poised to transform patient care, streamline clinical decision-making and contribute to a paradigm shift in the fight against sepsis. Stay tuned for insights, innovations, and the latest advancements in diagnostic technology that will shape the future of healthcare. Read the full blog here: https://lnkd.in/dhRC3fXn . . #diasysindia #blog #blogpost #procalcitonin #sepsis #antibiotic #insights
True that, Procalcitonin is biggest leading indicator for Sepsis. It can Show Traces of Severity of Sepsis too. Combined with PCR's can prove to be a Best Combination..
Our first blog is now live! In this blog, we will unravel the intricate web of Procalcitonin's significance in identifying sepsis early on and optimizing antibiotic treatment. Let us explore how this biomarker is poised to transform patient care, streamline clinical decision-making and contribute to a paradigm shift in the fight against sepsis. Stay tuned for insights, innovations, and the latest advancements in diagnostic technology that will shape the future of healthcare. Read the full blog here: https://lnkd.in/dhRC3fXn . . #diasysindia #blog #blogpost #procalcitonin #sepsis #antibiotic #insights
Chronic Venous Insufficiency Market Growth Anticipated by 2034 | Companies includes Verigraft, MediWound, TissueTech, Amniox Medical: Chronic Venous Insufficiency Market Several factors are expected to accelerate the growth of the Chronic Venous Insufficiency market during the forecast period (2023–2034). Increased awareness about available treatments, rising disease prevalence, and heightened disease awareness are key drivers. In the … Continue reading → #Business #Europe #HealthMedicine #PharmaceuticalsBiotech #US
In Episode 10, Dr. Paul Frohna, MD, PhD, discusses the key adverse events linked to anti-fibrotic therapies and the need for developing new pharmacotherapies to better treat idiopathic and progressive pulmonary fibrosis. Watch here: https://bit.ly/4edqYy6 #PulmonaryCare #IPF #ProgressivePulmonaryFibrosis #AntiFibroticTherapies #ClinicalResearch #ManagedCare
Innovation is in our DNA. Our robust therapeutic portfolio is the result of keen insights into multiple disease states for which we’re developing potential treatments, including plasma and non-plasma solutions alike. The next wave of Grifols innovation has the potential to significantly transform #healthcare. Discover our key therapeutic areas. ?? #WeAreHealthcare #healthcareinnovation
Progression-free survival and overall survival benefits of adding chemotherapy to gefitinib were sustained at 5 years, confirming earlier results reported at median follow-up of 17 months. https://ja.ma/49N5F3m
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
A patient-led organization has just made an incredible breakthrough by repurposing a drug for a rare and deadly bleeding condition! Recently, a large clinical trial revealed that pomalidomide, originally developed for multiple myeloma, has proven effective in treating a life-threatening bleeding disorder called HHT (Hereditary Hemorrhagic Telangiectasia). This drug not only reduced bleeding events but also improved patients’ quality of life. Cure HHT brought together physicians, researchers, and patients to push this repurposing opportunity forward, showing the true power of patient-led organizations. At Every Cure, we?aim to?work closely with patient organizations to identify the most promising opportunities from our platform and ensure the necessary trials are conducted to benefit as many patients as possible. Because no one understands a rare disease better than those living with it. #raredisease #drugdevelopment #drugrepurposing #clinicaltrial
Medical Insurance Specialist | Medical Coding
6 个月Just wanted to make your company aware that there is a man by the name of Arthur Long reaching out to people for remote job with your company. He is using the number 615-537-2473. And an Hr manager Scarlet Faust. Thought your company would like to know. I reported the scam to BBB.org. Hope this helps. He is giving out your companies website as well.?